Log In
BCIQ
Print this Print this
 

PM181104

  Manage Alerts
Collapse Summary General Information
Company Piramal Enterprises Ltd.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationStaphylococcus
Indication DetailsTreat methicillin-resistant Staphylococcus aureus (MRSA)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today